NDAORALTABLET
Approved
Jan 1962
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 4h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Winstrol (stanozolol) is an oral anabolic-androgenic steroid approved in 1962 for treating hereditary angioedema and select hematologic conditions. It functions as a synthetic androgen receptor agonist that promotes protein synthesis and red blood cell production. The product is now primarily used in niche therapeutic areas with limited modern clinical development.
LOE Approaching
With LOE approaching and minimal commercial activity, career opportunities are limited to maintenance roles rather than growth-oriented positions.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Winstrol offers limited career growth potential due to its lifecycle stage (LOE Approaching) and minimal linked job openings (0 currently tracked). This role is suited for professionals seeking stable, niche expertise rather than career acceleration or innovation-driven impact.
Brand ManagerProduct Manager
Worked on WINSTROL at Lundbeck? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.